1 / 9

Introduction to Medicines and Health in Malaysia

Explore Malaysia's healthcare landscape, including tobacco use, diabetes rates, cancer treatment costs, drug procurement, budget constraints, and medication affordability. Learn about patenting issues in the Trans-Pacific Partnership Agreement negotiations.

carlosb
Download Presentation

Introduction to Medicines and Health in Malaysia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introduction to Medicines and Health in Malaysia FifaRahman, LLB, MHL Policy Manager, Malaysian AIDS Council

  2. Malaysia • 44% of Malaysian males are current tobacco smokers.Ministry of Health, Malaysia, Global adult tobacco survey 2011 factsheet. http://www.moh.gov.my/images/gallery/Report/GATS_Malaysia.pdf (2011, accessed 6 November 2012) • 21% of Malaysians are diabeticHew FL and Hussein Z. Diabetes – the new Malaysian epidemic. The Star Online [Internet]. 2012 Jul 22 [cited 2012 Jul 22]; Available from: http://thestar.com.my/health/story.asp?file=/2012/7/22/health/11702759&sec=health • breast cancer, accounting for 18% of all cancers. Malaysia. Ministry of Health. Non-Communicable Disease Section. National cancer registry report 2007. Putrajaya: Ministry of Health; 2007 • 14,986 deaths related to HIV/AIDS Ministry of Health statistics, Malaysia

  3. Malaysia • Pharmacists recommended generic substitution for 84.7% of the brand name medicine requests. Chong CP, Hassali MA, Bahari MB and Shafie AA. Generic medicine substitution practices among community pharmacists: a nationwide study from Malaysia. Journal of Public Health 2011; 19(1): 81-90. • 2005, Procurement of meds RM1.12 billion. Ministry of Health, Malaysian Statistics on Medicine 2005  • In 2007, MYR 800 million ($ 260 million) Babar ZUD, Ibrahim MIM, Singh H, Bukahri NI, Creese A. Evaluating drug prices, availability, affordability, and price components: Implications for access to drugs in Malaysia. PLoS Med 2007; 4(3): e82. doi:10.1371/journal.pmed.0040082 • 14.7% increase in drug expenditure in 2007 as compared to 2006. Ministry of Health, Malaysian Statistics on Medicine 2007 • Most expensive drug for breast cancer Herceptin, MYR 8000 ($2,600) per cycle, 17 cycles needed, costs MYR 136,000 ($44,000) Breast Cancer Welfare Association Malaysia, personal communication. • In the state of Malacca from 2011-2012, budget for medicines procurement was reduced from MYR 49.61 million ($16m) to MYR 35.30 million ($11.4m) Citizen Journalists Malaysia http://cj.my/post/41297/krisis-catuan-bekalan-ubat-di-hospital-melaka-berlarutan/ • Treating a lung cancer patient costs an average of MYR 44,725 ($14,455) per year per patient. Aljunid S.M, Rizal A.M, Abrizah A, Sharifah Z.S.Y, Zarihah M.Z, Rahmat A, Zulkifli A, COST OF SMOKING AMONG PATIENTS WITH LUNG CANCER (2006) • Mean household income of MYR 4,025 ($ 1,313) per month.Department of Statistics, Malaysia, Household income and basic amenities survey report 2009. http://www.statistics.gov.my/portal/index.php?option=com_content&view=article&id=1640&Itemid=169&lang=en (2009, accessed 6 November 2012)

  4. How/Where Negotiations Carried Out Fancy hotel, stakeholder presentations, stakeholder briefing, confidentiality agreements, Barbara Weisel, decisions by political leaders.

  5. Threatening Meds Provisions in the TPPA • Patent extensions ~ LiowTiong Lai • Patenting of surgical, diagnostic, therapeutic method. • Data exclusivity • Patenting of new uses and forms Original med (HIV) Original med + salt (HIV) Original med + salt (cures cancer)  7 years data exclusivity  12 years data exclusivity (biologic)  make it into liquid etcetc South Africa

  6. Here’s the Whopper! 12 years of data exclusivity for biologic medicines. Eg. Nexavar, Herceptin, Glivec, Pegylated Interferon

  7. Impact? • Delay of generic medicines – Jordan – $18 million per year ~ Abbott, Ryan B. et al. ‘The price of medicines in Jordan: the cost of trade-based intellectual property.’ (2012) 9(2) Journal of Generic Medicines 75-85 • ECOSOC Report of the Secretary-General: ‘fundamental objectives… painfully evident… higher than the gains… consistent increase’ ~Para 3, IP Rights and Human Rights, Report of the Secretary-General, E/CN.4/Sub. 2/2001/12 • Anand Grover: ‘undermine the safeguards… developing countries… TRIPS… countries need… assess… potential health violations… all stages of negotiation…’ ~Para 69 and 70, UN General Assembly, Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover, A/HRC/11/12 (31 March 2009)

  8. Things Americans Say (and do) • US abstained from voting on UN Resolution on access to medicines – “encourage innovation” (13 June 2013) http://www.keionline.org/node/1748 • “Nothing that has been proposed in TPP would constrain the Malaysian government from subsidisingmedicines” Paul Allen Brown, article in Malaysian Insider, 29 May 2013 http://www.themalaysianinsider.com/litee/sideviews/article/trans-pacific-partnership-tpp-regional-free-trade-agreement-negotiations-clarifying-some-issues-paul-a.-brown/ • FifaRahman in response: http://www.themalaysianinsider.com/sideviews/article/a-response-to-paul-allen-brown-fifa-rahman

More Related